Robert Rosenfield to Adolescent
This is a "connection" page, showing publications Robert Rosenfield has written about Adolescent.
Connection Strength
1.298
-
Perspectives on the International Recommendations for the Diagnosis and Treatment of Polycystic Ovary Syndrome in Adolescence. J Pediatr Adolesc Gynecol. 2020 Oct; 33(5):445-447.
Score: 0.077
-
The Diagnosis of Polycystic Ovary Syndrome in Adolescents. Pediatrics. 2015 Dec; 136(6):1154-65.
Score: 0.056
-
Commentary: Launch of a quality improvement network for evidence-based management of uncommon pediatric endocrine disorders: Turner syndrome as a prototype. J Clin Endocrinol Metab. 2015 Apr; 100(4):1234-6.
Score: 0.053
-
Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood. J Clin Endocrinol Metab. 2015 Apr; 100(4):1537-43.
Score: 0.053
-
The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum. J Pediatr Adolesc Gynecol. 2015 Dec; 28(6):412-9.
Score: 0.051
-
Clinical review: Adolescent anovulation: maturational mechanisms and implications. J Clin Endocrinol Metab. 2013 Sep; 98(9):3572-83.
Score: 0.048
-
Comparison of detection of normal puberty in girls by a hormonal sleep test and a gonadotropin-releasing hormone agonist test. J Clin Endocrinol Metab. 2013 Apr; 98(4):1591-601.
Score: 0.046
-
Comparison of detection of normal puberty in boys by a hormonal sleep test and a gonadotropin-releasing hormone agonist test. J Clin Endocrinol Metab. 2012 Dec; 97(12):4596-604.
Score: 0.045
-
Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril. 2012 Jul; 98(1):242-9.
Score: 0.044
-
Normal pubertal development: part II: clinical aspects of puberty. Pediatr Rev. 2011 Jul; 32(7):281-92.
Score: 0.041
-
Potential diagnostic utility of intermittent administration of short-acting gonadotropin-releasing hormone agonist in gonadotropin deficiency. Fertil Steril. 2010 Dec; 94(7):2697-702.
Score: 0.038
-
Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population. J Clin Endocrinol Metab. 2009 May; 94(5):1579-86.
Score: 0.035
-
Blunted sleep-related luteinizing hormone rise in healthy premenarcheal pubertal girls with elevated body mass index. J Clin Endocrinol Metab. 2009 Apr; 94(4):1168-75.
Score: 0.035
-
Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index. Pediatrics. 2009 Jan; 123(1):84-8.
Score: 0.035
-
Improving balance in regulatory oversight of research in children and adolescents: a clinical investigator's perspective. Ann N Y Acad Sci. 2008; 1135:287-95.
Score: 0.032
-
Does a primary acceleration of LH pulse frequency underlie an association between central precocious puberty and polycystic ovary syndrome? Commentary on Escobar ME et al: Acceleration of LH pulse frequency in adolescent girls with a history of central precocious puberty with versus without hyperandrogenism (Horm Res 2007;68:278-285). Horm Res. 2007; 68(6):286-7.
Score: 0.031
-
Intractable early childhood obesity as the initial sign of insulin resistant hyperinsulinism and precursor of polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2007 Jan; 20(1):41-51.
Score: 0.030
-
Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab. 2007 Mar; 92(3):787-96.
Score: 0.030
-
Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome. J Clin Endocrinol Metab. 2006 Apr; 91(4):1275-83.
Score: 0.028
-
A workshop on pubertal hormone replacement options in the United States. J Pediatr Endocrinol Metab. 2006 Jan; 19(1):55-64.
Score: 0.028
-
Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin North Am. 2005 Sep; 34(3):677-705, x.
Score: 0.028
-
Hyperhidrosis as the only manifestation of hyperandrogenism in an adolescent girl. Arch Dermatol. 2000 Mar; 136(3):430-1.
Score: 0.019
-
Optimizing estrogen replacement in adolescents with Turner syndrome. Ann N Y Acad Sci. 2000; 900:213-4.
Score: 0.019
-
Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism. J Pediatr Endocrinol Metab. 2000; 13 Suppl 5:1285-9.
Score: 0.019
-
Optimizing estrogen replacement treatment in Turner syndrome. Pediatrics. 1998 Aug; 102(2 Pt 3):486-8.
Score: 0.017
-
A pilot study of the human chorionic gonadotrophin test for ovarian hyperandrogenism. Hum Reprod. 1997 Jul; 12(7):1416-20.
Score: 0.016
-
Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys--a clinical research center study. J Clin Endocrinol Metab. 1995 Oct; 80(10):2980-6.
Score: 0.014
-
Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1994 Dec; 79(6):1686-92.
Score: 0.013
-
Maturation of the normal pituitary-testicular axis, as assessed by gonadotropin-releasing hormone agonist challenge. J Clin Endocrinol Metab. 1994 Jun; 78(6):1336-40.
Score: 0.013
-
Menstrual disorders in adolescence. Endocrinol Metab Clin North Am. 1993 Sep; 22(3):491-505.
Score: 0.012
-
Acne, hirsutism, and alopecia in adolescent girls. Clinical expressions of androgen excess. Endocrinol Metab Clin North Am. 1993 Sep; 22(3):507-32.
Score: 0.012
-
Potential of gonadotropin-releasing hormone agonists in the diagnosis of pubertal disorders in girls. Clin Obstet Gynecol. 1993 Sep; 36(3):773-85.
Score: 0.012
-
Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1993 Feb; 76(2):450-5.
Score: 0.011
-
Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J Clin Endocrinol Metab. 2012 Jul; 97(7):E1342-7.
Score: 0.011
-
Puberty and its disorders in girls. Endocrinol Metab Clin North Am. 1991 Mar; 20(1):15-42.
Score: 0.010
-
Hyperandrogenism in peripubertal girls. Pediatr Clin North Am. 1990 Dec; 37(6):1333-58.
Score: 0.010
-
Clinical review 6: Diagnosis and management of delayed puberty. J Clin Endocrinol Metab. 1990 Mar; 70(3):559-62.
Score: 0.009
-
Use of nafarelin for testing pituitary-ovarian function. J Reprod Med. 1989 Dec; 34(12 Suppl):1044-50.
Score: 0.009
-
Growth hormone deficiency impedes the rise in plasma insulin-like growth factor I levels associated with precocious puberty. J Pediatr. 1989 Jul; 115(1):64-8.
Score: 0.009
-
Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009 Apr; 123(4):e752-62.
Score: 0.009
-
The relationship of mild hirsutism or acne in women to androgens. Arch Dermatol. 1987 Feb; 123(2):209-12.
Score: 0.008
-
Pubertal data for growth velocity charts. J Pediatr. 1986 Sep; 109(3):564-5.
Score: 0.007
-
Functional significance of polycystic-size ovaries in healthy adolescents. J Clin Endocrinol Metab. 2006 Oct; 91(10):3786-90.
Score: 0.007
-
Low-dose testosterone effect on somatic growth. Pediatrics. 1986 Jun; 77(6):853-7.
Score: 0.007
-
Pilosebaceous physiology in relation to hirsutism and acne. Clin Endocrinol Metab. 1986 May; 15(2):341-62.
Score: 0.007
-
The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics. J Clin Endocrinol Metab. 1985 Sep; 61(3):508-13.
Score: 0.007
-
Physiologic testosterone or estradiol induction of puberty increases plasma somatomedin-C. J Pediatr. 1985 Sep; 107(3):415-7.
Score: 0.007
-
Dexamethasone preparation does not alter corticoid and androgen responses to adrenocorticotropin. J Clin Endocrinol Metab. 1985 Mar; 60(3):585-9.
Score: 0.007
-
GnRH agonist stimulation of the pituitary-gonadal axis in children: age and sex differences in circulating inhibin-B and activin-A. Hum Reprod. 2004 Dec; 19(12):2748-58.
Score: 0.006
-
Advances in diagnosis and treatment of short stature, with special reference to the role of growth hormone. J Pediatr. 1984 Jun; 104(6):801-13.
Score: 0.006
-
Puberty in girls born to infertile women after gonadotropin therapy. JAMA. 1983 Dec 16; 250(23):3201.
Score: 0.006
-
Toward optimal estrogen-replacement therapy. N Engl J Med. 1983 Nov 03; 309(18):1120-1.
Score: 0.006
-
Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome. J Pediatr. 1983 Mar; 102(3):461-4.
Score: 0.006
-
The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries. Hum Reprod. 2002 Jan; 17(1):88-91.
Score: 0.005
-
Induction of puberty in the hypogonadal girl--practices and attitudes of pediatric endocrinologists in Europe. Horm Res. 2002; 57(1-2):66-71.
Score: 0.005
-
Pubertal presentation of congenital delta 5-3 beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1980 Aug; 51(2):345-53.
Score: 0.005
-
Amenorrhea related to progestin excess in congenital adrenal hyperplasia. Obstet Gynecol. 1980 Aug; 56(2):208-15.
Score: 0.005
-
Gonadotropin-releasing hormone infusion test in the distinction of hypopituitary patients from normal subjects. Fertil Steril. 1979 May; 31(5):507-12.
Score: 0.004
-
Plasma free androgen patterns in hirsute women and their diagnostic implications. Am J Med. 1979 Mar; 66(3):417-21.
Score: 0.004
-
Linkage of congenital isolated adrenocorticotropic hormone deficiency to the corticotropin releasing hormone locus using simple sequence repeat polymorphisms. Am J Med Genet. 1996 Mar 29; 62(3):262-7.
Score: 0.004
-
Persistent testicular delta5-isomerase-3beta-hydroxysteroid dehydrogenase (delta5-3beta-HSD) deficiency in the delta5-3beta-HSD form of congenital adrenal hyperplasia. J Clin Invest. 1975 Apr; 55(4):681-90.
Score: 0.003
-
Sertoli-Leydig cell tumor of the ovary, with an associated mucinous cystadenoma. An ultrastructural and endocrine study. Lab Invest. 1974 Dec; 31(6):648-57.
Score: 0.003
-
The effects of prolonged physiologic estradiol therapy on the maturation of hypogonadal teen-agers. J Pediatr. 1974 Dec; 85(6):830-7.
Score: 0.003
-
Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab. 1994 Nov; 79(5):1328-33.
Score: 0.003
-
The response to human chorionic gonadotropin (HCG) administration in boys with and without delta5-3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1974 Aug; 39(2):370-4.
Score: 0.003
-
Detection and functional characterization of the novel missense mutation Y254D in type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene of a female patient with nonsalt-losing 3 beta HSD deficiency. J Clin Endocrinol Metab. 1994 Mar; 78(3):561-7.
Score: 0.003
-
The effects of low doses of depot estradiol and testosterone in teenagers with ovarian failure and Turner's syndrome. J Clin Endocrinol Metab. 1973 Oct; 37(4):574-80.
Score: 0.003
-
Maturation of gonadotropin and sex steroid responses to gonadotropin-releasing hormone agonist in males. J Clin Endocrinol Metab. 1993 Feb; 76(2):362-6.
Score: 0.003
-
Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 1992 Jul 16; 327(3):157-62.
Score: 0.003
-
Managing delayed puberty. Postgrad Med. 1972 May; 51(5):204-9.
Score: 0.003
-
Plasma testosterone binding globulin and indexes of the concentration of unbound plasma androgens in normal and hirsute subjects. J Clin Endocrinol Metab. 1971 Jun; 32(6):717-28.
Score: 0.003
-
Androgens and androgen responsiveness in the feminizing testis syndrome. Comparison of complete and "incomplete" forms. J Clin Endocrinol Metab. 1971 May; 32(5):625-32.
Score: 0.003
-
A new test of combined pituitary-testicular function using the gonadotropin-releasing hormone agonist nafarelin in the differentiation of gonadotropin deficiency from delayed puberty: pilot studies. J Clin Endocrinol Metab. 1989 Nov; 69(5):963-7.
Score: 0.002
-
Plasma 17-ketosteroid levels during adolescence. J Pediatr. 1969 Jun; 74(6):932-6.
Score: 0.002
-
Plasma testosterone and dehydroepiandrosterone sulfate during puberty. J Pediatr. 1969 May; 74(5):830-1.
Score: 0.002
-
Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 1989 Mar 02; 320(9):559-65.
Score: 0.002
-
Sex hormone-binding globulin in the diagnosis of peripheral tissue resistance to thyroid hormone: the value of changes after short term triiodothyronine administration. J Clin Endocrinol Metab. 1988 Apr; 66(4):740-6.
Score: 0.002
-
A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt. Am J Dis Child. 1987 May; 141(5):562-4.
Score: 0.002
-
Idiopathic anterior hypopituitarism in one of monozygous twins. J Pediatr. 1967 Jan; 70(1):115-7.
Score: 0.002
-
Studies of androgen metabolism and action in cultured hair and skin cells. J Steroid Biochem. 1986 May; 24(5):1053-60.
Score: 0.002
-
Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. J Clin Endocrinol Metab. 1986 May; 62(5):840-8.
Score: 0.002
-
Administration of low-dose estrogen rapidly and directly stimulates growth hormone production. Am J Dis Child. 1986 Feb; 140(2):124-7.
Score: 0.002
-
Plasma androgens in women with acne vulgaris. J Invest Dermatol. 1983 Jul; 81(1):70-4.
Score: 0.001
-
Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women. J Clin Endocrinol Metab. 1982 Aug; 55(2):251-7.
Score: 0.001
-
Bioactive luteinizing hormone pituitary reserves during normal and abnormal male puberty. J Clin Endocrinol Metab. 1982 Jul; 55(1):140-6.
Score: 0.001
-
Adrenarche: changing adrenal response to adrenocorticotropin. J Clin Endocrinol Metab. 1981 Jun; 52(6):1129-36.
Score: 0.001
-
Estradiol-testosterone binding interactions and free plasma estradiol under physiological conditions. J Clin Endocrinol Metab. 1981 May; 52(5):868-74.
Score: 0.001
-
LH bioactivity increases more than immunoreactivity during puberty. J Pediatr. 1980 Aug; 97(2):205-13.
Score: 0.001
-
Reduction of the potency of luteinizing hormone by estrogen. N Engl J Med. 1979 May 03; 300(18):1034-6.
Score: 0.001
-
Partial gonadotrophin-resistance in pseudohypoparathyroidism. Acta Endocrinol (Copenh). 1978 Jun; 88(2):321-8.
Score: 0.001
-
Growth retardation and zinc nutrition. Pediatr Res. 1976 Nov; 10(11):923-7.
Score: 0.001
-
Endocrinologic characteristics of partial ovarian failure. J Clin Endocrinol Metab. 1976 Aug; 43(2):449-52.
Score: 0.001
-
The levodopa test of growth hormone reserve in children. Am J Dis Child. 1973 Nov; 126(5):589-92.
Score: 0.001
-
Hyperleydigism: a cause of severe pubertal gynecomastia. J Clin Endocrinol Metab. 1971 Jun; 32(6):751-6.
Score: 0.001
-
The plasma growth hormone response to insulin-induced hypoglycemia in children with retardation of growth. Pediatrics. 1967 Jun; 39(6):844-52.
Score: 0.000